Antibody complexes of hapten-modified diagnostic or therapeutic agents
CA 1282069 C · Owner: Meyer, Damon L. · Inventors: David, Gary S.; Meyer, Damon L.; Bartholomew, Richard M.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Antibody complexes comprising hapten-modified diagnostic or therapeutic agents and anti-hapten antibodies are disclosed. Administration of haptenmodified agents such as p-bromoacetamidobenzyl EDTA(BABE)-CL232,468, BABE-Co Bleomycin and the indium complex of p-isothiocyanobenzyl EDTA linked to mitomycin C, complexed with suitable anti-hapten antibodies extends the serum half-life and permit an increased concentration of such diagnostic or therapeutic agents at in vivo target sites.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted March 26, 1991. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended March 26, 2008.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.